dementia
Amprion Wins Additional $730K NIH Grant to Validate Parkinson's Disease Test
The recently launched test is designed to detect a-synuclein aggregates to aid in the diagnosis of Parkinson's disease and other brain conditions.
Centogene, Alector Partner to ID Frontotemporal Dementia Patients With Genetic Mutations
The EFRONT study aims to enroll more than 3,000 FTD patients for genetic testing at centers in Belgium, Germany, Greece, Italy, Portugal, Spain, and Turkey.
CND Life Sciences Wins $2.4M NIH Grant to Develop Synucleinopathy Test
The test is designed to detect and visualize abnormal phosphorylated alpha-synuclein — a hallmark of synucleinopathies — in cutaneous nerve fibers.
Alzheimer's Drug Discovery Foundation Awards $5.5M in Grants for Diagnostic Development
The grants were awarded through the organization's Diagnostic Accelerator, a partnership between the charity and various philanthropic partners.
Biosignatures Closes £3.5M in Funding
The financing, led by Accelerated Digital Ventures, will go toward the development of 20 tests targeted at cancers and dementias.